What Fueled The Previous Growth In The Diagnostic Enzyme Market?
The diagnostic enzyme market has seen considerable growth due to a variety of factors.
• There has been prominent growth in the size of the diagnostic enzyme market in the past few years. The market is expected to expand from $4.25 billion in 2024 to $4.49 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.7%.
Factors contributing to this historical growth include the escalating prevalence of chronic diseases, a surge in the elderly population, an upturn in healthcare expenditure, government interventions, and heightened consciousness about preventive healthcare.
How Does the Forecast Look for the Diagnostic Enzyme Market?
The diagnostic enzyme market is expected to maintain its strong growth trajectory in upcoming years.
• Over the coming years, the diagnostic enzyme market size is anticipated to experience robust growth. It's projected to reach $5.92 billion in 2029 with a compound annual growth rate (CAGR) of 7.1%.
This growth within the predicted period can be credited to factors such as increased demand for point-of-care testing, intensifying interest in personalized medicine, growing needs for companion and molecular diagnostics, and in vitro diagnostics. Also, the robust expansion in the biotechnology industry contributes significantly. The key trends within this forecasted period would be personalized enzyme solutions, advancements in automation and robotics, biomarker identification, incorporation of digital health, green enzymes, and efforts towards sustainability.
What Are The Leading Drivers Of Growth In The Diagnostic Enzyme Market?
The increase in the elderly population is predicted to drive the expansion of the diagnostic enzymes market in the future. The elderly population, also called the geriatric population, comprises individuals who are 65 years and older. Diagnostic enzymes are essential for this population as they are used to diagnose and monitor diseases associated with aging, and this population group is more prone to chronic illnesses that necessitate diagnostic enzyme testing. For example, a report released by the United Nations, a US-based intergovernmental organization, in November 2022 revealed that the global population aged 65 and above is predicted to increase from 10% in 2022 to 16% by 2050. The report also projected that by 2050, the worldwide number of people aged 65 and older will be double that of children under 5 and about the same as children under 12. Thus, the growing geriatric population is boosting the diagnostic enzymes market growth.
How Are The Segments Defined Within The Global Diagnostic Enzyme Market?
The diagnostic enzyme market covered in this report is segmented –
1) By Product Type: Carbohydrases, Polymerases And Nucleases, Protease, Other Product Types
2) By Source: Animals, Microorganisms, Plants
3) By Application: Biocatalysts, Diagnostics, Pharmaceuticals, Research & Biotechnology
Subsegments:
1) By Carbohydrases: Amylases, Cellulases, Lactases, Glucosidases
2) By Polymerases And Nucleases: DNA Polymerases, RNA Polymerases, Restriction Endonucleases, Exonucleases
3) By Protease: Serine Proteases, Cysteine Proteases, Metalloproteases, Aspartic Proteases
4) By Other Product Types: Oxidoreductases, Transferases, Lyases, Hydrolases
Pre-Book The Diagnostic Enzyme Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Diagnostic Enzyme Industry?
The diagnostic enzymes market is seeing a rising trend of employing machine learning and artificial intelligence. AI, which imitates human intellectual capabilities in machines, and machine learning, a subset of AI, are aiding businesses in the enzyme diagnostic sector. They allow a comprehensive review of all pertinent data, shed light on enzyme operations, and enable doctors to unravel the significant factors of the connection between protein framework, function, and evolution, especially in relation to enzyme reaction step catalysis. As an example, BioMarker is a company that has put resources into AI and machine learning for enzyme diagnosis.
Who Are the Key Players In The Diagnostic Enzyme Market?
Major companies operating in the diagnostic enzyme market include:
• Sanofi S.A.
• Advanced Enzymes Technologies
• Aldevron LLC
• Amano Enzymes Inc.
• Codexis Inc.
• EKF Diagnostic
• Kaneka Eurogentec
• Roche Holding AG
• Sekisui Diagnostics LLC
• Thermo Fisher Scientific Inc.
• Charles River Laboratories
• Biocatalysts
• Merck & Co. Inc.
• Chr. Hansen
• Kerry Group
• Dyadic International
• Creative Enzymes
• Pfizer Inc.
• Eli Lilly and Company
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc
• Johnson & Johnson
• AbbVie Inc.
• Amgen Inc.
• Biogen Inc.
• Gilead Sciences Inc.
• Regeneron Pharmaceuticals Inc.
What Is The Most Dominant Region In The Diagnostic Enzyme Market?
North America was the largest region in the enzymes market in 2024. Middle East is expected to be the fastest-growing region in the diagnostic enzyme market report during the forecast period. The regions covered in the diagnostic enzyme market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
